Identification of nonconserved amino acids in the AT1 receptor which comprise a general binding site for biphenylimidazole antagonists

FEBS Letters

Volumn 394, Issue 3, 1996, Pages 361-364

  Nirula, Vaneet ^a   Zheng, Wei ^a   Krishnamurthi, Kamakshi ^a   Sandberg, Kathryn ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Angiotensin AT1 receptor; Biphenylimidazole; Imidazoleacrylic acid; Nonpeptide antagonist; Site directed mutagenesis

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN II [1 SARCOSINE 8 ISOLEUCINE]; ANGIOTENSIN RECEPTOR; EPROSARTAN; IMIDAZOLE DERIVATIVE; LOSARTAN; RECEPTOR SUBTYPE;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BINDING SITE; CELL STRAIN COS1; CONTROLLED STUDY; DRUG RECEPTOR BINDING; FROG; GENE EXPRESSION; GENE TRANSFER; MUTATION; NONHUMAN; PLASMID; PRIORITY JOURNAL; RAT; SPECIES DIFFERENCE;

AMPHIBIA; ANIMALIA; ANURA; MAMMALIA;

EID: 0030574024     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-5793(96)00961-1     Document Type: Article

References (20)

1. [1] Raizada, M.K., Phillips, I.A. and Sumners, C. (1993) Cellular and Molecular Biology of the Renin Angiotensin System, CRC Press, Boca Raton, FL.
2. [2] Timmermans, P.B., Wong, P.C., Chiu, A.T., Herblin, W.F. and Smith, R.D. (1993) J. Hum. Hypertens. 7 Suppl. 2, S19-31.
3. [3] Sandberg, K. (1994) Trends Endo. Metab. 5, 28-35.
4. [4] Timmermans, P.B.M.W.M., Wong, P.C., Chiu, A.T., Herblin, W.F., Benfield, P., Carini, D.J., Lee, R.J., Wexler, R.R., Saye, J.A.M. and Smith, R.D. (1993) Pharmacol. Rev. 45, 205-251.
5. [5] Furukawa, Y., Kishimoto, S. and Nishikawa, K. (1982) United States Patent (1982) 4, 340,598.
6. [6] Smith, R.D., Chiu, A.T., Wong, P.C., Herblin, W.F., and Timmermans, P.B.M.W.M. (1992) Annu. Rev. Pharmacol. Toxicol. 32, 135-165.
7. [7] Keenan, R.M., Weinstock, J., Finkelstein, J.A., Franz, R.G., Gaitanopoulos, D.E., Girard, G.R., Hill, D.T., Morgan, T.M., Samanen, J.M., Peishoff, C.E., Tucker, L.M., Aiyar, N., Griffin, E., Ohlstein, E.H., Stack, E.J., Weidley, E.F. and Edwards, R.M. (1993) J. Med. Chem. 36, 1880-1892.
8. [8] Sandberg, K., Ji, H., Millan, M.A. and Catt, K.J. (1991) FEBS Lett. 284, 281-284.
9. [9] Ji, H., Leung, M., Zhang, Y., Catt, K.J. and Sandberg, K. (1994) J. Biol. Chem. 269, 16533-16536.
10. [10] Schambye, H., Hjorth, S.A., Bergsma, D.J., Sathe, G. and Schwartz, T.W. (1994) Proc. Natl. Acad. Sci. USA 91, 7046-7050.
11. [11] Schambye, H., Hjorth, S.A., Weinstock, J. and Schwartz, T.W. (1995) Mol. Pharmacol. 47, 425-431.
12. [12] Groblewski, T., Maigret, B., Nonet, S., Larguier, R., Lombard, C., Bonnafous, J.C. and Marie, J. (1995) Biochem. Biophys. Res. Commun. 209, 153-160.
13. [13] Ji, H., Zheng, W., Zhang, Y., Catt, K.J. and Sandberg, K. (1995) Proc. Natl. Acad. Sci. USA 92, 9240-9244.
14. [14] Sandberg, K., Ji, H., Clark, A.J., Shapira, H. and Catt, K.J. (1992) J. Biol. Chem. 267, 9455-9458.
15. [15] Ji, H., Sandberg, K., Zhang, Y. and Catt, K.J. (1993) Biochem. Biophys. Res. Commun. 194, 756-762.
16. [16] Nirula, V., Zheng, W., Sothinathan, R. and Sandberg, K. (1996) Br. J. Pharmacol., in press.
17. [17] Schwartz, T.W. (1994) Curr. Opìn. Bìotech. 5, 434-444.
18. [18] Cascieri, M.A., Gong, T.M. and Strader, C.D. (1995) J. Pharmacol. Toxicol. Methods 33, 179-185.
19. [19] Hjorth, S.A., Schambye, H.T., Greenlee, W.J. and Schwartz, T.W. (1994) J. Biol. Chem. 269, 30953-30959.
20. [20] Feng, Y.-H., Noda, K., Saad, Y., Liu, X-p., Husain, A. and Karnik, S.S. (1995) J. Biol. Chem. 270, 12846-12850.